259 related articles for article (PubMed ID: 34221975)
1. Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma.
Liu B; Su Q; Ma J; Chen C; Wang L; Che F; Heng X
Front Oncol; 2021; 11():657002. PubMed ID: 34221975
[TBL] [Abstract][Full Text] [Related]
2. Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
Xu C; Xu H; Liu B
PeerJ; 2023; 11():e16364. PubMed ID: 38025757
[TBL] [Abstract][Full Text] [Related]
3. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
4. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
5. Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma.
Zheng H; Liu H; Lu Y; Li H
Front Surg; 2021; 8():717084. PubMed ID: 34631779
[No Abstract] [Full Text] [Related]
6. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
7. Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Jiang Y; Li Y; Ge H; Wu Y; Zhang Y; Guo S; Zhang P; Cheng J; Wang Y
J Oral Pathol Med; 2021 Nov; 50(10):1040-1049. PubMed ID: 34358365
[TBL] [Abstract][Full Text] [Related]
8. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction.
Li Q; Jin Y; Shen Z; Liu H; Shen Y; Wu Z
Int J Gen Med; 2021; 14():10117-10129. PubMed ID: 34992433
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
[TBL] [Abstract][Full Text] [Related]
12. A novel hypoxia-associated gene signature for prognosis prediction in head and neck squamous cell carcinoma.
Luo J; Huang Y; Wu J; Dai L; Dong M; Cheng B
BMC Oral Health; 2023 Nov; 23(1):864. PubMed ID: 37964257
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an immune-related gene prognostic model for head and neck tumors.
Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
[TBL] [Abstract][Full Text] [Related]
14. Constructing a T-Cell Receptor-Related Gene Signature for Prognostic Stratification and Therapeutic Guidance in Head and Neck Squamous Cell Carcinoma.
Lu Y; Mai Z; Zheng J; Lin P; Lin Y; Cui L; Zhao X
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067199
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
[TBL] [Abstract][Full Text] [Related]
16. Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma.
Ye F; Wu P; Zhu Y; Huang G; Tao Y; Liao Z; Guan Y
Front Genet; 2022; 13():989081. PubMed ID: 36338975
[No Abstract] [Full Text] [Related]
17. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
Ding Z; Li H; Yu D
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes.
Peng G; Chi H; Gao X; Zhang J; Song G; Xie X; Su K; Song B; Yang J; Gu T; Li Y; Xu K; Li H; Liu Y; Tian G
Front Genet; 2022; 13():1010044. PubMed ID: 36406133
[No Abstract] [Full Text] [Related]
19. Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Zhu C; Wu Q; Yang N; Zheng Z; Zhou F; Zhou Y
Front Genet; 2022; 13():848841. PubMed ID: 35586567
[No Abstract] [Full Text] [Related]
20. Investigation of an FGFR-Signaling-Related Prognostic Model and Immune Landscape in Head and Neck Squamous Cell Carcinoma.
Chen Q; Chu L; Li X; Li H; Zhang Y; Cao Q; Zhuang Q
Front Cell Dev Biol; 2021; 9():801715. PubMed ID: 35237609
[No Abstract] [Full Text] [Related]
[Next] [New Search]